Qiu, Xiaoxing

USPTO Trademark & Patent Filings

Qiu Xiaoxing

Trademark applications and grants for Qiu, Xiaoxing. Qiu, Xiaoxing has 5 trademark applications. The latest application filed is for "MOISKIL"

Company Profile
    Company Aliases
  • Qiu Xiaoxing
  • Qiu, Xiaoxing
  • xiaoxing qiu
  • Qiu; Xiaoxing - Abbott Park IL
  • Qiu; Xiaoxing - Gurnee IL
  • Qiu; Xiaoxing - Gumee IL
Entity Type INDIVIDUAL
Address Room 1202, No. 563 Hubin Middle Road, Siming District, Xiamen, Fujian CHINA 361012

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks Patents
Patent Applications
Patent ApplicationDate
DIRECT DETECTION OF SINGLE MOLECULES ON MICROPARTICLES
20200209250 - 16/729067 Ruan; Qiaoqiao ;   et al.
2020-07-02
MONOCLONAL ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS AND USES THEREOF
20130130233 - 13/647735 Lou; Sheng C. ;   et al.
2013-05-23
Markers of XMRV Infection And Uses Thereof
20120288516 - 13/475596 Qiu; Xiaoxing ;   et al.
2012-11-15
MARKERS OF XMRV INFECTION AND USES THEREOF
20120171235 - 13/414356 Qiu; Xiaoxing ;   et al.
2012-07-05
MONOCLONAL ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS AND USES THEREOF
20120100632 - 13/024093 Lou; Sheng C. ;   et al.
2012-04-26
Monoclonal antibodies to human immunodeficiency virus and uses thereof
9,115,189 - 13/647,735 Lou , et al. August 25, 2
2015-08-25
Markers of XMRV infection and uses thereof
8,183,349 - 12/828,161 Qiu , et al. May 22, 2
2012-05-22
Methods for the detection of HIV-1 or -2 antigens employing monoclonal antibodies that recognize a shared HIV-1/-2 epitope in the capsid p24/p26 proteins
7,897,332 - 10/714,689 Lou , et al. March 1, 2
2011-03-01
Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26).
7,531,642 - 10/940,392 Lou , et al. May 12, 2
2009-05-12
Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
7,531,639 - 10/940,261 Lou , et al. May 12, 2
2009-05-12
Patent Grants & Applications

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed